Virtu Financial’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-11,233
| Closed | -$25K | – | 1544 |
|
|
2024
Q2 | $25K | Buy |
+11,233
| New | +$25K | ﹤0.01% | 1003 |
|
|
2023
Q1 | – | Sell |
-39,169
| Closed | -$44K | – | 1706 |
|
|
2022
Q4 | $44K | Buy |
39,169
+26,345
| +205% | +$29.6K | 0.01% | 1107 |
|
|
2022
Q3 | $21K | Buy |
+12,824
| New | +$21K | ﹤0.01% | 1385 |
|
|
2022
Q2 | – | Sell |
-16,261
| Closed | -$26K | – | 1754 |
|
|
2022
Q1 | $26K | Sell |
16,261
-1,402
| -8% | -$2.24K | ﹤0.01% | 1260 |
|
|
2021
Q4 | $37K | Buy |
+17,663
| New | +$37K | ﹤0.01% | 1408 |
|
|
2021
Q2 | – | Sell |
-14,683
| Closed | -$32K | – | 1698 |
|
|
2021
Q1 | $32K | Buy |
+14,683
| New | +$32K | ﹤0.01% | 1476 |
|
|
2019
Q4 | $157K | Buy |
+54,738
| New | +$157K | 0.02% | 993 |
|
|
2018
Q4 | – | Sell |
-17,752
| Closed | -$107K | – | 1690 |
|
|
2018
Q3 | $107K | Buy |
+17,752
| New | +$107K | 0.01% | 1173 |
|